Biotech Values

[apljack]

Genoptix (GXDX) has stopped trading as it has aqreed to be acquired by Novartis.

I still hold a large position in Neogenomics (NGNM). I haven't posted anything in a while as they haven't done anything of note except to continue to grow at a healthy pace. Last quarter they broke the $10 million revenue barrier but are still operating at about break even. Still no word from the co. about publication of their MelanoSite melanoma differential diagnostic test and by now, they should have been able to report that these data were in line for publication, so I am skeptical that the data will ever be published. Without publication, the new test will remain a small piece of their overall revenue stream.

aj